Data suggest the therapy can induce prolonged clinical benefit, even after treatment discontinuation.
Ira Winer, MD, PhD
Advertisement
Articles by Ira Winer, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
2
Targeted α-Particle Radioligand Therapy Shows Promising Activity, Low Toxicity in SSTR2-Positive Neuroendocrine Tumors
3
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
4
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
5
